Navigation Links
MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at the 33rd Annual Deutsche Bank Healthcare Conference
Date:4/28/2008

CORAL GABLES, Fla., April 28 /PRNewswire-FirstCall/ -- MBF Healthcare Acquisition Corp. (Amex: MBH), a publicly traded special purpose acquisition company, announced today that it and Critical Homecare Solutions Holdings, Inc. ("CHS"), a privately-owned, leading provider of comprehensive home infusion therapy and specialty infusion services, are scheduled to present on Monday, May 5, 2008 at the 33rd Annual Deutsche Bank Healthcare Conference in Boston, MA. On February 6, 2008, MBH signed a definitive stock purchase agreement with CHS. Presenting at the conference from CHS will be Bob Cucuel, President and Chief Executive Officer, and MJ Graves, Chief Financial Officer.

Event: Deutsche Bank Health Care Conference

Date: Monday, May 5, 2008

Time: 4:00 p.m. ET

Place: The InterContinental Boston, Boston, MA

An audio Web cast of the presentation will be on the investor relations section of the CHS website at http://www.criticalhs.com. A replay of the presentation will be available for 15 days.

About MBF Healthcare Acquisition Corp.

MBH is a blank check company formed for the purpose of acquiring, through a merger, capital stock exchange, stock purchase, asset acquisition or other similar business combination, one or more operating business in the healthcare industry.

About Critical Homecare Solutions Holdings, Inc.

CHS is a leading provider of comprehensive home infusion therapy and specialty infusion services to patients suffering from acute or chronic conditions. CHS delivers over 400,000 infusion pharmaceuticals, biopharmaceuticals, nutrients and related services each year to patients in the home through 33 in
'/>"/>

SOURCE MBF Healthcare Acquisition Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
2. Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30, 2008
3. Isolagen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
5. Exelixis Announces April 30 Webcast of Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Pharmasset to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, April 30th
8. NeurogesX to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference
9. BioMarin to Present at the Morgan Stanley Healthcare Conference
10. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Biodel Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference April 30th 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015  Prima Biomed Ltd. (NASDAQ: PBMD ) ... become a leader in the development of immunotherapeutic products ... final CVac data from the Phase II CAN-003 ovarian ... a clinically meaningful improvement in Overall Survival ("OS") over ... In the group of second remission patients (n=20), ...
(Date:5/21/2015)... , May 21, 2015 ... inner feelings - and those of others. Being able ... senses. Analyze and read people to anticipate their thoughts ... your deepest emotions and feelings to create unique abstract ... of responsive games. Get inside a first-person-shooter as it ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
(Date:5/21/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... focused on the development of autologous cell therapies, ... International Society for Cellular Therapy (ISCT) on RepliCel,s ... in a Phase 1/2 clinical trial.  The presentation, ... 5:30 PM to 7:00 PM local time, will ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
... June 17 Schering-Plough,Corporation (NYSE: SGP ) is ... 2008 second quarter on Monday, July 21, 2008., ... conduct a conference,call to review results for the 2008 ... members of management will,host the conference call., To ...
... 17 Mergent, Inc., administrator for the,HealthShares(TM) Indexes, ... Exchange Traded Funds, today announced the quarterly,rebalancing of ... and,deleted in the Indexes effective before the opening ... HealthShares(TM) Autoimmune-Inflammation Index (HHA), Drop, ...
... NEW HAVEN, Conn., June 17 BioXcel ... ASDO Consulting Group,(ASDO), a leading consulting company ... global business analytics company, will combine forces ... of,services. These include business analytics to support,licensing/due-diligence, ...
Cached Biology Technology:Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings 2Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 2Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 3Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 4Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 5Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 6Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 7Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 8Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 9Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 10Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 11Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 12Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 13Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 14Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 15Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 16Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 17Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 18Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 19Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 20Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 21Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 22Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 23Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 24Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 25Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 26Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 27Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 28Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 29Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 30Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 31Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 32Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 33BioXcel Expands Its Capability in Business Analytics Support Services 2
(Date:5/14/2015)... 14, 2015 Research and Markets ( ... "Fingerprint Sensors Market in Smart Mobile Devices " ... that 2014 was a watershed year for fingerprint sensors ... ,Apple Pay,. Apple gave fingerprint sensors a raison d,etre ... Fingerprint sensors are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... a large epidemiologic study, researchers at UCLA,s Jonsson Cancer ... are at higher risk of having retinoblastoma, a malignant ... under six. The study, which focused on babies ... fathers were at greater risk for retinoblastoma, as were ...
... can encounter a host of health complications. The added weight ... at least initially. In a new study published in ... a University of Iowa researcher compared the weight and height ... born to normal-weight mothers. Contrary to expectations, babies ...
... -- A commercial vaccine for cattle can effectively reduce levels ... a Kansas State University study has found. The vaccine is ... doses, which can help cut costs for the beef industry. ... investigator on a project that researched the effectiveness of products ...
Cached Biology News:US-born Latinas at great risk of having babies with retinoblastoma 2Infants of overweight mothers grow more slowly 2Infants of overweight mothers grow more slowly 3A new line of defense: Researchers find cattle vaccine works to reduce E. coli O157:H7 2
... cultured in DMEM with 4 mM L-glutamine medium ... In order to keep the antigens in ... The cells are arrayed on a 12-well ... surface specifically treated to enhance cellular attachment and ...
... DMEM and harvested at the log phase of ... in their native forms, cells were fixed in ... 12-well (5 mm) adhesive coated slide, with each ... and to minimize background staining. Each well ...
... in DMEM and harvested at the log phase ... antigens in their native forms, cells were fixed ... a 12-well (5 mm) adhesive coated slide, with ... attachment and to minimize background staining. Each ...
...
Biology Products: